| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |